Ipca-Escitalopram Tablets

New Zealand - English - Medsafe (Medicines Safety Authority)

Active ingredient:
Escitalopram oxalate 6.37 mg equivalent to Escitalopram 5 mg
Available from:
Ipca Pharma (NZ) Pty Limited
INN (International Name):
Escitalopram oxalate 6.37 mg (equivalent to Escitalopram 5 mg)
Dosage:
5 mg
Pharmaceutical form:
Film coated tablet
Composition:
Active: Escitalopram oxalate 6.37 mg equivalent to Escitalopram 5 mg Excipient: Colloidal silicon dioxide Croscarmellose sodium Hypromellose Macrogol 400 Magnesium stearate Microcrystalline cellulose Purified talc   Purified water Titanium dioxide
Prescription type:
Prescription
Manufactured by:
Neuland Laboratories Limited
Therapeutic indications:
In adults: Treatment of major depression. Treatment of social anxiety disorder (social phobia). Treatment of generalised anxiety disorder. Treatment of obsessive-compulsive disorder.
Product summary:
Package - Contents - Shelf Life: Blister pack, PVDC/PVC/Aluminium - 14 tablets - 36 months from date of manufacture stored at or below 30°C. Keep in a dry place - Blister pack, PVDC/PVC/Aluminium - 28 tablets - 36 months from date of manufacture stored at or below 30°C. Keep in a dry place - Blister pack, PVDC/PVC/Aluminium - 56 tablets - 36 months from date of manufacture stored at or below 30°C. Keep in a dry place - Blister pack, PVDC/PVC/Aluminium - 98 tablets - 36 months from date of manufacture stored at or below 30°C. Keep in a dry place
Authorization number:
TT50-9828b
Authorization date:
2015-08-03

Similar products

Search alerts related to this product

Share this information